1792P Effects of enzalutamide on overall survival +/- early docetaxel in participants aged less than 70 yrs versus greater than or equal to 70 yrs in ENZAMET (ANZUP 1304)

Lisa G. Horvath; Ian D. Davis; Andrew Martin; R. Zielinski; Alastair Thomson; Thean Hsiang Tan; Shahneen Sandhu; M. Neil Reaume; David Pook; Francis Parnis; Scott North; Gavin Marx; John A. McCaffrey; Ray McDermott; Nicola Jane Lawrence; Mark Frydenberg; S. Chowdhury; K.N. Chi; Martin R. Stockler; Christopher J. Sweeney

doi:10.1016/j.annonc.2023.09.2742

Related publications

Article2022

Updated overall survival outcomes in ENZAMET (ANZUP 1304), an international, cooperative group trial of enzalutamide in metastatic hormone-sensitive prostate cancer (mHSPC).

Ian D. Davis, Andrew Martin, Robert Zielinski, Alastair Thomson, Thean Hsiang Tan, Shahneen Sandhu, M. Neil Reaume, David Pook, Francis Parnis, Scott North, Gavin Marx, John McCaffrey, Ray McDermott, Nicola Jane Lawrence, Lisa G. Horvath, Mark Frydenberg, Simon Chowdhury, Kim N., Martin R. Stockler, Christopher Sweeney

Article2025

8-year outcomes of enzalutamide (ENZA) versus a non-steroidal anti-androgen (NSAA) for metastatic, hormone-sensitive prostate cancer (ENZAMET; ANZUP 1304).

Alison Yan Zhang, Ian D. Davis, Hayley Thomas, Ronan Andrew McLaughlin, Thean Hsiang Tan, David Pook, Gavin Marx, Robert Zielinski, Shahneen Sandhu, Alastair Thomson, M. Neil Reaume, Scott North, John McCaffrey, Ray McDermott, Nicola Jane Lawrence, Lisa G. Horvath, Simon Chowdhury, Kim N., Martin R. Stockler, Christopher Sweeney

Article2024

Prognostic implications of PSA levels at 7 months in metastatic hormone-sensitive prostate cancer treated with enzalutamide: Landmark analysis of ENZAMET (ANZUP 1304).

Ronan Andrew Mc Laughlin, Hayley Thomas, Ian D. Davis, Robert Zielinski, Alastair Thomson, Thean Hsiang Tan, Shahneen Sandhu, M. Neil Reaume, David Pook, Francis Parnis, Scott North, Gavin Marx, John McCaffrey, Ray McDermott, Lisa G. Horvath, Mark Frydenberg, Simon Chowdhury, Kim N., Martin R. Stockler, Christopher Sweeney

Article2025

Enzalutamide with standard first-line therapy for metastatic hormone-sensitive prostate cancer: a plain language summary of the ENZAMET trial (ANZUP 1304)

Ciara Conduit, Andrisha–Jade Inderjeeth, R.J. Allen, Andrew Martin, Wendy R. Parulekar, Eibhlin Mulroe, Margaret McJannett, Robert Zielinski, Alastair Thomson, Thean Hsiang Tan, Shahneen Sandhu, M. Neil Reaume, David Pook, Scott North, Gavin Marx, Anthony M. Joshua, Lisa G. Horvath, Ray McDermott, Simon Chowdhury, Kim N., Alison Y. Zhang, Martin R. Stockler,

Article2011

Regional Correlations of VS30 and Velocities Averaged Over Depths Less Than and Greater Than 30 Meters

D. M. Boore, Eric M Thompson, Héloïse Cadet

Bulletin of the Seismological Society of America